CRISPR/Cas 9: the science and the future
Daniel Liefwalker, PhD
Dr. Liefwalker utilizes genome editing CRISR/Cas9 systems, in vivo models, computational and molecular approaches to investigate mechanisms of tumor development and regression. He currently works in the Division of Oncology, School of Medicine, Stanford CA.
His PhD work encompassed development of drug screens, biological characterization, in silico modeling, mechanisms of action, and science communication. He examined the drugs that activated the tumor suppressive functions of a gene called AhR, and carefully characterized the molecular mechanisms that induce AhR-dependent tumor suppressive endpoints.
Location: Donner Laboratorium Auditorium at UC Berkeley
The meeting will be held at the auditorium of the Donner Lab Building at the UC Berkeley campus. Click here for campus map. The building is locked in the evening, but the auditorium is right by the entrance door, so if you knock, we can hear you and open the door for you.
Street parking along Hearst Ave. should not be difficult in the evening. For on-campus parking, click here for UC Berkeley parking website.
Participants are welcome to join us for dinner at the Faculty Club after the meeting at your own expense.
Please RSVP by emailing email@example.com so that we can make a reservation at the Faculty Club.
Papers to be discussed
|File Size:||4305 kb|
|File Size:||2507 kb|